Evidence for specific TRPM8 expression in human prostate secretory epithelial cells: functional androgen receptor

G Bidaux1, M Roudbaraki, C Merle

  • 1Laboratoire de Physiologie Cellulaire, INSERM EMI 0228, Bâtiment SN3, Université des Sciences et Technologies de Lille, 59655 Villeneuve d'Ascq Cedex, France.

Insights

The melastatine-related transient receptor potential member 8 (TRPM8) gene is directly regulated by androgens in prostate cells. TRPM8 expression is linked to differentiated prostate epithelial cells and may help predict prostate cancer progression.

Area of Science:

  • Molecular Biology
  • Urology
  • Cancer Research

Background:

  • Melastatine-related transient receptor potential member 8 (TRPM8) is a cation channel protein.
  • TRPM8 mRNA is overexpressed in prostate cancer and plays a role in prostate physiology.
  • Androgen regulation of TRPM8 is crucial for understanding prostate cancer development.

Purpose of the Study:

  • To determine the mechanisms of androgen regulation for TRPM8 mRNA expression.
  • To identify the phenotype of TRPM8-expressing cells in the human prostate.
  • To investigate the role of TRPM8 in prostate cancer progression.

Main Methods:

  • Single-cell reverse transcriptase PCR.
  • Immunohistochemical experiments.
  • Androgen receptor functional assays.

Main Results:

  • TRPM8 gene expression is dependent on a functional androgen receptor.
  • The TRPM8 gene is a primary androgen-responsive gene.
  • TRPM8 is mainly expressed in apical secretory epithelial cells; its expression decreases with loss of differentiation.

Conclusions:

  • Androgen-regulated TRPM8 expression is vital for understanding prostate cancer progression to androgen-independence.
  • TRPM8 mRNA levels could be a biomarker for predicting prostate cancer status.
  • Further research into TRPM8's function in normal prostate and cancer is warranted.